This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

USPTO’s Stewart touts ‘significant efficiencies’ of PTAB changes

By Nick Robertson ( March 31, 2025, 22:46 GMT | Insight) -- US Patent and Trademark Office acting Director Coke Morgan Stewart told MLex that changes to the Patent Trial and Appeal Board’s discretionary denial process will help the board use fewer resources and focus on more important patent challenges. The office has radically changed the institutional process in recent weeks, rescinding a 2022 memo and bifurcating the decision-making process entirely by directly including the director.Recent actions by the US Patent and Trademark Office changing the discretionary denial process at the Patent Trial and Appeal Board have come under criticism from attorneys and former PTAB judges, but acting Director Coke Morgan Stewart told MLex she stands by the changes....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections